metoclopramide has been researched along with Disease Models, Animal in 33 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined whether metoclopramide (MCP), a modulator of dopamine and serotonin receptors, alleviated colitis and had synergistic effects when coadministered with 5-aminosalicylic acid (5-ASA) in an experimental model of colitis." | 7.91 | A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model. ( Jeong, S; Jung, Y; Kim, D; Kim, W; Yang, Y; Yoo, JW, 2019) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin (PRL) and prolactin receptor's (PRLR) expression in the adrenal." | 7.81 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal. ( Baracat, EC; Carvalho, KC; da Silva, PL; do Amaral, VC; Maciel, GA; Simoncini, T; Soares, JM, 2015) |
| "Metoclopramide is often used in the treatment of postoperative nausea and vomiting, but a literature review failed to find reports on the influence of this drug on the healing of bowel anastomoses in the setting of abdominal sepsis." | 7.79 | Effects of metoclopramide on healing of colonic anastomoses in a rat model of abdominal sepsis. ( Carneiro, FP; Ferreira, VM; Marques e Silva, S; Oliveira, PG; Sousa, JB, 2013) |
| "To evaluate the effects of metoclopramide on abdominal wall healing in rats in the presence of sepsis." | 7.77 | Influence of metoclopramide on abdominal wall healing in rats subjected to colonic anastomosis in the presence of peritoneal sepsis induced. ( Brandão, AM; Carneiro, FP; Marques e Silva, S; Morais, PH; Oliveira, MV; Silva, NG; Sousa, JB, 2011) |
| "To evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium." | 7.76 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium. ( Baracat, EC; de Jesus Simões, M; Dos Santos Simões, R; Oliveira, PB; Rossi, AG; Soares, JM; Teixeira Gomes, RC, 2010) |
| "We examined the preventive effect of metoclopramide on the development of esophageal varices in a rat model." | 7.69 | Metoclopramide inhibits development of esophageal varices in rat model. ( Hashizume, M; Ishii, T; Kitano, S; Komori, K; Ohta, M; Sugimachi, K; Tanoue, K; Ueno, K, 1994) |
| "The impact of hyperprolactinaemia on endometrial function, along with embryo implantation, has been the subject of discussion." | 5.33 | Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice. ( Baptista, HA; Baracat, EC; da Motta, EL; de Jesus Simões, M; Haapalainen, EF; Haidar, MA; Júnior, JM; Panzan, MQ, 2006) |
| "We examined whether metoclopramide (MCP), a modulator of dopamine and serotonin receptors, alleviated colitis and had synergistic effects when coadministered with 5-aminosalicylic acid (5-ASA) in an experimental model of colitis." | 3.91 | A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model. ( Jeong, S; Jung, Y; Kim, D; Kim, W; Yang, Y; Yoo, JW, 2019) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the tibial epiphyseal plate of hormone-treated oophorectomized mice." | 3.83 | Effects of hyperprolactinemia on the tibial epiphyseal plate of mice treated with sex hormones. ( Baracat, EC; da Silva, PL; do Amaral, VC; Gomes, RC; Prosdocimi, FC; Simões, MJ; Simoes, RS; Simoncini, T; Soares, JM; Wolff, RB, 2016) |
| "The aim of this study was to evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin (PRL) and prolactin receptor's (PRLR) expression in the adrenal." | 3.81 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal. ( Baracat, EC; Carvalho, KC; da Silva, PL; do Amaral, VC; Maciel, GA; Simoncini, T; Soares, JM, 2015) |
| "Eighty rats were divided into two groups for euthanasia on the 3rd or 7th postoperative day (POD), then into two subgroups for sepsis induction or not, and then into subgroups to receive either metoclopramide or saline solution." | 3.81 | Effects of metoclopramide on the expression of metalloproteinases and interleukins in left colonic anastomoses. An experimental study. ( Bocca, AL; Jerônimo, MS; Marques e Silva, S; Silva-Pereira, Id; Sousa, JB; Tavares, AH, 2015) |
| "Metoclopramide is often used in the treatment of postoperative nausea and vomiting, but a literature review failed to find reports on the influence of this drug on the healing of bowel anastomoses in the setting of abdominal sepsis." | 3.79 | Effects of metoclopramide on healing of colonic anastomoses in a rat model of abdominal sepsis. ( Carneiro, FP; Ferreira, VM; Marques e Silva, S; Oliveira, PG; Sousa, JB, 2013) |
| "The data suggest that the combination of metoclopramide and ketamine synergistically controls acute pain in mice." | 3.78 | Antinociception by metoclopramide, ketamine and their combinations in mice. ( Al-Baggou, BKh; Mohammad, FK; Naser, AS, 2012) |
| "To evaluate the effects of metoclopramide on abdominal wall healing in rats in the presence of sepsis." | 3.77 | Influence of metoclopramide on abdominal wall healing in rats subjected to colonic anastomosis in the presence of peritoneal sepsis induced. ( Brandão, AM; Carneiro, FP; Marques e Silva, S; Morais, PH; Oliveira, MV; Silva, NG; Sousa, JB, 2011) |
| "To evaluate the effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium." | 3.76 | Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium. ( Baracat, EC; de Jesus Simões, M; Dos Santos Simões, R; Oliveira, PB; Rossi, AG; Soares, JM; Teixeira Gomes, RC, 2010) |
| " However, retching and vomiting were significantly inhibited by pretreatment with ondansetron and metoclopramide in cisplatin and copper sulfate groups (P=0." | 3.73 | Value of mink vomit model in study of anti-emetic drugs. ( Liu, ZT; Wang, L; Yang, ZH; Yue, W; Zhang, F, 2006) |
| " Cisplatin, apomorphine, copper sulfate and X-radiation were used to establish vomiting model." | 3.72 | [A new vomiting animal model--mink]. ( Fang, X; Liu, YX; Minami, M; Wang, L; Yue, W; Zhang, F, 2003) |
| "We examined the preventive effect of metoclopramide on the development of esophageal varices in a rat model." | 3.69 | Metoclopramide inhibits development of esophageal varices in rat model. ( Hashizume, M; Ishii, T; Kitano, S; Komori, K; Ohta, M; Sugimachi, K; Tanoue, K; Ueno, K, 1994) |
| "The antiemetic activity of DAU 6215, a novel antagonist of 5-HT3 receptors, was investigated in animal models of cytotoxic treatment-evoked emesis and compared with the antiemetic activity of ondansetron and metoclopramide." | 3.68 | Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation. ( Algate, DR; Bonali, P; Donetti, A; Micheletti, R; Montagna, E; Nicola, M; Rimoldi, EM; Sagrada, A; Schiantarelli, P; Turconi, M, 1991) |
| " Antagonism with metoclopramide provided complete protection from cisplatin-induced emesis." | 3.66 | Cisplatin-induced emesis in the Ferret: a new animal model. ( Bradner, WT; Florczyk, AP; Schurig, JE, 1982) |
| "Metoclopramide is shown to suppress trigeminovascular activation for the first time, providing an experimental basis for its role in migraine." | 1.46 | Metoclopramide inhibits trigeminovascular activation:evidence for effective acute attack treatment in migraine. ( Akçali, DT; Bolay, H; Doğanay Aydin, H; Vuralli, D, 2017) |
| "Hyperprolactinemia was closely correlated with HMG, and hyperprolactinemia promoted the formation of HMG." | 1.39 | Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice. ( Chen, YG; Li, JY; Li, ZH; Liu, XG; Ma, L; Wang, X; Wu, JH; Zou, JL, 2013) |
| "Metoclopramide probably has a mechanism of action to prevent U46619-induced emesis via 5-HT(4) receptor activation and NK(1) tachykinin receptor antagonists could be useful to prevent emesis induced by TP receptor activation in man." | 1.35 | Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret. ( Kan, KK; Ngan, MP; Rudd, JA; Wai, MK, 2008) |
| "The impact of hyperprolactinaemia on endometrial function, along with embryo implantation, has been the subject of discussion." | 1.33 | Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice. ( Baptista, HA; Baracat, EC; da Motta, EL; de Jesus Simões, M; Haapalainen, EF; Haidar, MA; Júnior, JM; Panzan, MQ, 2006) |
| "The effect of hyperprolactinaemia on the prostate has still not been fully elucidated." | 1.32 | The expression of androgen receptors in the epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinaemia: a morphological and immunohistochemical study. ( Kram, A; Laszczyńska, M; Piasecka, M; Słuczanowska-Głabowska, S; Wylot, M, 2003) |
| "This "injection-conditioned catalepsy" was also observed after repeated treatment with the dopamine D2 antagonists, haloperidol and metoclopramide." | 1.30 | Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice. ( Chinen, CC; Frussa-Filho, R, 1999) |
| "Emesis was characterized by expulsion of solid or liquid material." | 1.29 | Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents. ( Göthert, M; Herold, H; Szelenyi, I, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (9.09) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 6 (18.18) | 29.6817 |
| 2010's | 16 (48.48) | 24.3611 |
| 2020's | 2 (6.06) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Wolfes, J | 1 |
| Ellermann, C | 1 |
| Burde, S | 1 |
| Fehr, M | 1 |
| Eckardt, L | 1 |
| Frommeyer, G | 1 |
| Yang, Y | 1 |
| Kim, W | 1 |
| Kim, D | 1 |
| Jeong, S | 1 |
| Yoo, JW | 1 |
| Jung, Y | 1 |
| Abd Ellah, NH | 1 |
| Ahmed, EA | 1 |
| Abd-Ellatief, RB | 1 |
| Ali, MF | 1 |
| Zahran, AM | 1 |
| Hetta, HF | 1 |
| Marques e Silva, S | 3 |
| Carneiro, FP | 2 |
| Ferreira, VM | 1 |
| Oliveira, PG | 1 |
| Sousa, JB | 3 |
| Gomes, RC | 2 |
| Maioral, GC | 1 |
| Verna, C | 1 |
| Patriarca, MT | 1 |
| Nader, HB | 1 |
| Simões, RS | 2 |
| Baracat, EC | 5 |
| Soares, JM | 4 |
| Yilmaz Dilsiz, O | 1 |
| Akhundzada, I | 1 |
| Bilkay, U | 1 |
| Uyanikgil, Y | 1 |
| Teymur, H | 1 |
| Ates, U | 1 |
| Baka, M | 1 |
| Wang, X | 1 |
| Chen, YG | 1 |
| Ma, L | 1 |
| Li, ZH | 1 |
| Li, JY | 1 |
| Liu, XG | 1 |
| Zou, JL | 1 |
| Wu, JH | 1 |
| Wolff, RB | 1 |
| do Amaral, VC | 2 |
| da Silva, PL | 2 |
| Simoncini, T | 2 |
| Prosdocimi, FC | 1 |
| Simões, MJ | 1 |
| Carvalho, KC | 1 |
| Maciel, GA | 1 |
| Jerônimo, MS | 1 |
| Silva-Pereira, Id | 1 |
| Tavares, AH | 1 |
| Bocca, AL | 1 |
| Doğanay Aydin, H | 1 |
| Vuralli, D | 1 |
| Akçali, DT | 1 |
| Bolay, H | 1 |
| Kan, KK | 1 |
| Ngan, MP | 1 |
| Wai, MK | 1 |
| Rudd, JA | 1 |
| Rossi, AG | 1 |
| Teixeira Gomes, RC | 1 |
| de Jesus Simões, M | 2 |
| Dos Santos Simões, R | 1 |
| Oliveira, PB | 1 |
| Levin, R | 1 |
| Calzavara, MB | 1 |
| Santos, CM | 1 |
| Medrano, WA | 1 |
| Niigaki, ST | 1 |
| Abílio, VC | 1 |
| Silva, NG | 1 |
| Brandão, AM | 1 |
| Oliveira, MV | 1 |
| Morais, PH | 1 |
| Mohammad, FK | 1 |
| Al-Baggou, BKh | 1 |
| Naser, AS | 1 |
| Wang, D | 1 |
| Wong, HK | 1 |
| Zhang, L | 1 |
| McAlonan, GM | 1 |
| Wang, XM | 1 |
| Sze, SC | 1 |
| Feng, YB | 1 |
| Zhang, ZJ | 1 |
| Yue, W | 2 |
| Zhang, F | 2 |
| Wang, L | 2 |
| Fang, X | 1 |
| Liu, YX | 1 |
| Minami, M | 1 |
| Słuczanowska-Głabowska, S | 1 |
| Laszczyńska, M | 1 |
| Wylot, M | 1 |
| Piasecka, M | 1 |
| Kram, A | 1 |
| Yang, ZH | 1 |
| Liu, ZT | 1 |
| Panzan, MQ | 1 |
| Júnior, JM | 1 |
| da Motta, EL | 1 |
| Haapalainen, EF | 1 |
| Baptista, HA | 1 |
| Haidar, MA | 1 |
| Hattori, N | 1 |
| Nakayama, Y | 1 |
| Kitagawa, K | 1 |
| Li, T | 1 |
| Inagaki, C | 1 |
| Bárány, S | 1 |
| Häggström, JE | 1 |
| Gunne, LM | 1 |
| Florczyk, AP | 1 |
| Schurig, JE | 1 |
| Bradner, WT | 1 |
| Szelenyi, I | 1 |
| Herold, H | 1 |
| Göthert, M | 1 |
| Ohta, M | 1 |
| Hashizume, M | 1 |
| Tanoue, K | 1 |
| Ueno, K | 1 |
| Komori, K | 1 |
| Ishii, T | 1 |
| Kitano, S | 1 |
| Sugimachi, K | 1 |
| Duval, N | 1 |
| Grosset, A | 1 |
| O'Connor, SE | 1 |
| Chinen, CC | 1 |
| Frussa-Filho, R | 1 |
| Breiter, N | 1 |
| Sassy, T | 1 |
| Trott, KR | 1 |
| Sagrada, A | 1 |
| Turconi, M | 1 |
| Bonali, P | 1 |
| Schiantarelli, P | 1 |
| Micheletti, R | 1 |
| Montagna, E | 1 |
| Nicola, M | 1 |
| Algate, DR | 1 |
| Rimoldi, EM | 1 |
| Donetti, A | 1 |
| Marco, LA | 1 |
| Reed, TF | 1 |
| Joshi, RS | 1 |
| Aldes, LD | 1 |
| Chronister, RB | 1 |
33 other studies available for metoclopramide and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Proarrhythmic potential of metoclopramide in a sensitive whole-heart model.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Disease Models, Animal; Dopamine D2 Receptor | 2021 |
A colon-specific prodrug of metoclopramide ameliorates colitis in an experimental rat model.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Azo Compounds; Benzenesulfon | 2019 |
Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines.
Topics: Animals; Apoptosis; Calorimetry, Differential Scanning; Cytokines; Diabetes Mellitus, Experimental; | 2019 |
Effects of metoclopramide on healing of colonic anastomoses in a rat model of abdominal sepsis.
Topics: Abdominal Wall; Anastomosis, Surgical; Animals; Cecum; Colon; Disease Models, Animal; Hydroxyproline | 2013 |
Hyperprolactinemia changes the sulfated glycosaminoglycan amount on the murine uterus during the estrous cycle.
Topics: Animals; Biomarkers; Chondroitin Sulfates; Dermatan Sulfate; Disease Models, Animal; Estradiol; Estr | 2013 |
Effects of Metoclopramide and Ranitidine on survival of flat template McFarlane skin flaps in a rat wound healing model.
Topics: Animals; Disease Models, Animal; Immunohistochemistry; Male; Metoclopramide; Ranitidine; Rats; Rats, | 2014 |
Effect of Chinese medical herbs-Huiru Yizeng Yihao on hyperprolactinemia and hyperplasia of mammary gland in mice.
Topics: Animals; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Female; Gonadal Steroid Hormones; | 2013 |
Effects of hyperprolactinemia on the tibial epiphyseal plate of mice treated with sex hormones.
Topics: Androgens; Animals; Cartilage, Articular; Cell Proliferation; Disease Models, Animal; Dopamine D2 Re | 2016 |
Effects of metoclopramide-induced hyperprolactinemia on the prolactin and prolactin receptor expression of murine adrenal.
Topics: Adrenal Glands; Animals; Disease Models, Animal; Estradiol; Estrogens; Female; Hyperprolactinemia; I | 2015 |
Effects of metoclopramide on the expression of metalloproteinases and interleukins in left colonic anastomoses. An experimental study.
Topics: Anastomosis, Surgical; Animals; Antiemetics; Colon; Disease Models, Animal; Gene Expression; Interle | 2015 |
Metoclopramide inhibits trigeminovascular activation:evidence for effective acute attack treatment in migraine.
Topics: Animals; Brain Chemistry; Cortical Spreading Depression; Disease Models, Animal; Male; Metoclopramid | 2017 |
Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Antiemetics; Disease Mo | 2008 |
Effects of metoclopramide-induced hyperprolactinemia on the prolactin receptor of murine endometrium.
Topics: Animals; Disease Models, Animal; Endometrium; Estradiol; Female; Gene Expression Regulation; Hormone | 2010 |
Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
Topics: Acoustic Stimulation; Amphetamine; Animals; Antimanic Agents; Antipsychotic Agents; Carbamazepine; C | 2011 |
Influence of metoclopramide on abdominal wall healing in rats subjected to colonic anastomosis in the presence of peritoneal sepsis induced.
Topics: Abdominal Wall; Anastomosis, Surgical; Animals; Colon; Disease Models, Animal; Dopamine Antagonists; | 2011 |
Antinociception by metoclopramide, ketamine and their combinations in mice.
Topics: Acute Pain; Analgesics; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Syne | 2012 |
Not only dopamine D2 receptors involved in Peony-Glycyrrhiza Decoction, an herbal preparation against antipsychotic-associated hyperprolactinemia.
Topics: Animals; Bromocriptine; Cell Line; Disease Models, Animal; Dopamine; Dopamine D2 Receptor Antagonist | 2012 |
[A new vomiting animal model--mink].
Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Copper Sulfate; Disease Models, Animal; Male; Metoclop | 2003 |
The expression of androgen receptors in the epithelial cells of the rat prostate lateral lobe in experimental hyperprolactinaemia: a morphological and immunohistochemical study.
Topics: Animals; Disease Models, Animal; Endoplasmic Reticulum, Rough; Epithelial Cells; Fluorescent Antibod | 2003 |
Value of mink vomit model in study of anti-emetic drugs.
Topics: Animals; Antiemetics; Apomorphine; Cisplatin; Copper Sulfate; Disease Models, Animal; Enterochromaff | 2006 |
Metoclopramide-induced hyperprolactinaemia caused marked decline in pinopodes and pregnancy rates in mice.
Topics: Animals; Disease Models, Animal; Endometrium; Female; Hyperprolactinemia; Metoclopramide; Mice; Preg | 2006 |
Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
Topics: Animals; Autoantibodies; Disease Models, Animal; Dopamine Antagonists; Epitopes; Estrous Cycle; Fema | 2007 |
Application of a primate model for tardive dyskinesia.
Topics: Animals; Cebus; Disease Models, Animal; Dyskinesia, Drug-Induced; Female; Fluphenazine; Histamine An | 1983 |
Cisplatin-induced emesis in the Ferret: a new animal model.
Topics: Animals; Carnivora; Castration; Cisplatin; Disease Models, Animal; Ferrets; Male; Metoclopramide; Vo | 1982 |
Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents.
Topics: Animals; Antiemetics; Antineoplastic Agents; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; | 1994 |
Metoclopramide inhibits development of esophageal varices in rat model.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Esophageal and Gastric Varices; I | 1994 |
Combination of aspirin and metoclopramide produces a synergistic antithrombotic effect in a canine model of coronary artery thrombosis.
Topics: Animals; Aspirin; Blood Pressure; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Disea | 1997 |
Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Benzazepines; | 1999 |
[Acute and chronic disorders in gastric emptying after the x-ray irradiation of the rat stomach and their therapeutic modification].
Topics: Animals; Atropine; Carbachol; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Co | 1992 |
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.
Topics: Animals; Antiemetics; Benzimidazoles; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocy | 1991 |
Metoclopramide fails to suppress linguopharyngeal events in a rat dyskinesia model.
Topics: Animals; Deglutition; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Ind | 1989 |